Tissue repair in osteoradionecrosis using pentoxifylline and tocopherol--report of three cases
- PMID: 26251132
- DOI: 10.1007/s10006-015-0522-5
Tissue repair in osteoradionecrosis using pentoxifylline and tocopherol--report of three cases
Abstract
Purpose: Osteoradionecrosis is a complication of head and neck radiotherapy, with a difficult resolution and no well-established treatment. The disease progression can cause important loss on patient's quality of life after cancer treatment. The options for treatment are limited and include clinical monitoring, prescription, or surgical procedures. As an alternative for bone necrosis treatment, a combination of drugs, pentoxifylline and tocopherol, can be used. Studies have shown that this combination significantly reduces chronic radiotherapy damage. The article reports successful treatment with this prescription protocol.
Methods: We report three cases of patients referred to the Service of Oral and Maxillofacial Surgery at Erasto Gaertner Hospital, in Curitiba, Brazil. They were submitted to radiotherapy for the treatment of malignant head and neck tumors and later developed osteoradionecrosis. They were treated with the combination pentoxifylline and tocopherol.
Results: All patients achieved complete remission in less than 1 year, with complete healing of bone exposure and without clinical symptoms.
Conclusions: This results show that this combination of drugs is beneficial in cases of bone necrosis induced by radiation, avoiding more aggressive treatments and reducing morbidity.
Keywords: Osteoradionecrosis; Pentoxifylline; Radiotherapy; Tocopherol.
Similar articles
-
The efficacy of pentoxifylline/tocopherol combination in the treatment of osteoradionecrosis.Spec Care Dentist. 2015 Nov-Dec;35(6):268-71. doi: 10.1111/scd.12124. Epub 2015 Jun 17. Spec Care Dentist. 2015. PMID: 26084886
-
Medical treatment of osteoradionecrosis of the mandible by PENTOCLO: preliminary results.Eur Ann Otorhinolaryngol Head Neck Dis. 2014 Dec;131(6):333-338. doi: 10.1016/j.anorl.2013.11.006. Epub 2014 Jun 30. Eur Ann Otorhinolaryngol Head Neck Dis. 2014. PMID: 24993781
-
Complete restoration of refractory mandibular osteoradionecrosis by prolonged treatment with a pentoxifylline-tocopherol-clodronate combination (PENTOCLO): a phase II trial.Int J Radiat Oncol Biol Phys. 2011 Jul 1;80(3):832-9. doi: 10.1016/j.ijrobp.2010.03.029. Epub 2010 Jul 16. Int J Radiat Oncol Biol Phys. 2011. PMID: 20638190 Clinical Trial.
-
Osteoradionecrosis: a review of pathophysiology, prevention and pharmacologic management using pentoxifylline, α-tocopherol, and clodronate.Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Nov;124(5):464-471. doi: 10.1016/j.oooo.2017.08.004. Epub 2017 Aug 23. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017. PMID: 29103566 Review.
-
[Pentoxifylline and tocopherol - The importance in the treatment of osteoradionecrosis - Literature review and case report].Swiss Dent J. 2021 Sep 6;131(9):713-718. doi: 10.61872/sdj-2021-09-03. Swiss Dent J. 2021. PMID: 34472712 Review. German.
Cited by
-
The effects of pentoxifylline adminstration on fracture healing in a postmenopausal osteoporotic rat model.Lab Anim Res. 2017 Mar;33(1):15-23. doi: 10.5625/lar.2017.33.1.15. Epub 2017 Mar 27. Lab Anim Res. 2017. PMID: 28400835 Free PMC article.
-
Outcome of stereotactic body radiation for treatment of nasal and nasopharyngeal lymphoma in 32 cats.J Vet Intern Med. 2022 Mar;36(2):733-742. doi: 10.1111/jvim.16388. Epub 2022 Feb 21. J Vet Intern Med. 2022. PMID: 35188694 Free PMC article.
-
Postradiation Fractures after Combined Modality Treatment in Extremity Soft Tissue Sarcomas.Sarcoma. 2021 Mar 15;2021:8877567. doi: 10.1155/2021/8877567. eCollection 2021. Sarcoma. 2021. PMID: 33790687 Free PMC article. Review.
-
Pentoxifylline and tocopherol for the treatment of osteoradionecrosis of the jaws. A systematic review.Med Oral Patol Oral Cir Bucal. 2023 May 1;28(3):e293-e300. doi: 10.4317/medoral.25729. Med Oral Patol Oral Cir Bucal. 2023. PMID: 36641743 Free PMC article.
-
Oral health related-quality of life before and during the COVID-19 pandemic in patients with non-alcoholic fatty liver disease.Med Oral Patol Oral Cir Bucal. 2023 Jul 1;28(4):e310-e316. doi: 10.4317/medoral.25731. Med Oral Patol Oral Cir Bucal. 2023. PMID: 36641744 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials